Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2020 11:49 ET | Source: GeoVax, Inc.

Update: GeoVax Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial

Company Comments on NIH/NIAID Discontinuance of Sanofi/GSK HVTN 702 Trial ATLANTA, GA, Feb. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX) (OTC: GOVXD), a...
January 27, 2020 10:18 ET | Source: GeoVax, Inc.

GeoVax and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine

ATLANTA, GA, and WUHAN, CHINA, Jan. 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVXD), a biotechnology company developing human immunotherapies and vaccines against...
January 23, 2020 09:00 ET | Source: GeoVax, Inc.

GeoVax Announces Reverse Stock Split

1:2000 Reverse Split Effective January 24, 2020;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, Jan. 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTC: GOVX) today...